×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Haleon’s Otrivin® Brand Now Features Aptar’s First Nasal Pump Made with 52% Bio-based Material
By
Aptar Pharma
Aptar Pharma
29 Jul 2025
Dash Bio Secures $11M to Accelerate a New Era in Bioanalysis, Bringing Total Funding to $17.5M
By
Dash Bio
Dash Bio
23 Jul 2025
BD Announces the First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
By
BD
BD
23 Jul 2025
Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Gene Therapy Assets of Klotho Available
By
Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc.
22 Jul 2025
Avenacy Unveils the Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market
By
Avenacy
Avenacy
21 Jul 2025
Cronus Pharma Launches Butorphic® (Butorphanol Tartrate) as a Sterile Injectable Solution
By
Cronus Pharma LLC
Cronus Pharma LLC
21 Jul 2025
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Pharmaceutical
2nd International Conference on Stem Cells and Regenerative Medicine 2025
10 Nov 2025
10:00 am
- 11 Nov 2025
5:30 pm
USA
Pharmaceutical
2nd International Conference on Immunology & Vaccination 2025
10 Nov 2025
10:00 am
- 12 Nov 2025
5:30 pm
Paris
Most Popular
European Commission Approves Alteogen’s Aflibercept Biosimilar, EYLUXVI® (ALT-L9)
By
Alteogen Inc.
Sep 17
ENHERTU® Plus Pertuzumab Significantly Improves Progression-Free Survival vs. THP in 1st-Line Treatment for HER2+ Metastatic Breast Cancer
By
AstraZeneca
Apr 21
Cronus Pharma Launches Butorphic® (Butorphanol Tartrate) as a Sterile Injectable Solution
By
Cronus Pharma LLC
Jul 21
October
2025
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand
